CN1057692C - Chinese patent drug - Google Patents
Chinese patent drug Download PDFInfo
- Publication number
- CN1057692C CN1057692C CN97105284A CN97105284A CN1057692C CN 1057692 C CN1057692 C CN 1057692C CN 97105284 A CN97105284 A CN 97105284A CN 97105284 A CN97105284 A CN 97105284A CN 1057692 C CN1057692 C CN 1057692C
- Authority
- CN
- China
- Prior art keywords
- chinese patent
- radix
- patent medicine
- semen strychni
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 229940079593 drug Drugs 0.000 title description 4
- 206010005963 Bone formation increased Diseases 0.000 claims abstract description 12
- 239000004863 Frankincense Substances 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims description 14
- 238000011282 treatment Methods 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 241000717739 Boswellia sacra Species 0.000 claims description 7
- 241000903946 Clematidis Species 0.000 claims description 7
- 241001057584 Myrrha Species 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 239000009286 sanguis draxonis Substances 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000004576 sand Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 241000238370 Sepia Species 0.000 claims description 2
- 229940126678 chinese medicines Drugs 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 208000002193 Pain Diseases 0.000 abstract description 6
- 230000036407 pain Effects 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 3
- 239000008727 tongluo Substances 0.000 abstract 3
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000601164 Clematis orientalis Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241001300193 Speranskia Species 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 3
- 239000003513 alkali Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000018180 degenerative disc disease Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese patent medicine for treating hyperosteogeny, particularly to Tongluo Xiaoci powder which is prepared from astragalus root, white peony root, Chinese angelica root, frankincense, myrrh, ephedra, nux vomica, safflower, dragon's blood, Chinese clematis root and tuberculate speranskia herb. The Tongluo Xiaoci powder has the effects of strengthening healthy qi to eliminate pathogens, dredging the channels, dispelling wind, removing dampness, dissipating cold and relieving pains. When the Tongluo Xiaoci powder is used for treating hyperosteogeny, the advantages that the treating effect is obvious and accurate, the course is short, and the clinical effective rate is higher than 85% can be obtained.
Description
The invention belongs to a kind of oral Chinese patent medicine for the treatment of hyperosteogeny.
Hyperosteogeny is a kind of frequently-occurring disease, and main performance is disease sites and region of interest limitation of activity, and pain is serious, even the obvious spasm of muscle, Light-headedness, and numb limbs and tense tendons influences patient's orthobiosis and work greatly.Doctor trained in Western medicine thinks that this disease is because long-term strain, nerve root is upset or oppresses, and vertebral body and intervertebral disc degeneration, spinal canal stenosis etc. cause that general with traction or analgesic drug product, uncertain therapeutic efficacy is cut.The traditional Chinese medical science thinks that then this disease belongs to " arthromyodynia " category, generally adopts method treatments such as blood-activating and stasis-removing or manual massage.
The present invention aims to provide a kind of determined curative effect, short treating period, the oral Chinese patent medicine of the treatment hyperosteogeny that toxic and side effects is little.
The technical scheme that realizes above-mentioned purpose is characterised in that this Chinese patent medicine is made (b is Unit Weight part) with the following weight Chinese medicinal raw materials:
Radix Astragali 25-35b Radix Paeoniae Alba 12-18b Radix Angelicae Sinensis 12-18b Olibanum 16-24b
Myrrha 16-24b Herba Ephedrae 16-24b Semen Strychni 25-35b Flos Carthami 12-18b
Sanguis Draxonis 8-12b Radix Clematidis 16-24b Herba speranskiae tuberculatae 8-12b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
" Huang di's Canon of Medicine " thought: this three big factor affecting QI and blood of wound, strain and affection of exogenous wind-cold damp is normally moved, this be the main diseases that causes " arthromyodynia " because of.It is considered herein that except that above-mentioned factor deficiency of the liver and kindey is the endogenous cause of ill that causes above-mentioned exopathogen invasion.Therefore, the present invention is the principles of formulating prescriptions with " strengthening vital QI to eliminate pathogenic factors, dredge the meridian passage, expelling wind and removing dampness, dispersing cold for relieving pain ".
The Radix Astragali in the side, the Radix Paeoniae Alba are for setting upright QI invigorating, the product of suppressing the hyperactive liver and subsiding YANG, wherein the Radix Astragali contains astragalin and several amino acids, can strengthen the cells physiological metabolic function, and the Radix Paeoniae Alba has the effect (seeing " Chinese medicine modern study and clinical practice " Xueyuan Press 1995.6) of human body immunity improving function; Olibanum, Myrrha, Flos Carthami, Sanguis Draxonis are blood-activating stasis-removing kind Chinese medicine, have circulation of qi promoting to loose and stagnate, and the reducing swelling and alleviating pain effect is the product of traditional Chinese medical science traditional treatment rheumatalgia; When being classified as the product of enriching blood and invigorating blood circulation, modern medicine study confirms to have anti-inflammatory analgesic and anti-damaging action, and can human body immunity improving function (referring to " Chinese Chinese medicine magazine " 1,991 16 (11): 684) Herba Ephedrae has disperse function, contain biological alkali, but blood flow increasing, remarkable analgesic activity is arranged, and can resist the paralysis phenomenon of animal muscle; Semen Strychni mainly contains biological alkali, and reliable inhibition nervus centralis reflection and anticonvulsant action are arranged, and can benumb peripheral nerve, and the analgesic effect is arranged; Radix Clematidis, Herba speranskiae tuberculatae are expelling wind and removing dampness, removing obstruction in the collateral to relieve pain class Chinese medicine, and treatment articular instability, numb limbs and tense tendons are had sure effect.Full side's compatibility has strengthening vital QI to eliminate pathogenic factors, dredge the meridian passage, and expelling wind and removing dampness, the effect of dispersing cold for relieving pain both conformed to Traditional Chinese medical theory, and also the result of study with modern Chinese medicine is consistent.
Efficacy analysis
This medicine has been treated the thousands of examples of various hyperosteogeny patients, is 362 routine clinical efficacy statistics wherein below:
362 routine hyperosteogeny curative effect statistics
Invalid subtotal cervical vertebra hyperplasia 64 87 18 169 waists, knee joint hyperplasia 32 62 11 105 scapulohumeral periarthritis and rheumatalgia 21 24 9 54 other positions 7 11 16 34 totals 124 (34%) 184 (51%) 54 (15%) 362 of taking a turn for the better are almost recovered
By above statistics as can be known, all kinds of hyperosteogeny total effective rates of this group treatment are 85%, wherein to hyperosteogeny curative effect best (89%), do not see the person that has the toxicity.
Model case:
Cao Li, man, 40 years old, the engineer of Shanxi Province designing institute, December was examined on the 7th in 95 years, and patient's hyperosteogeny is more than 2 years, once sought medical advice how tame inside the province hospital with in, the western drug treatment is all invalid, now can not leave the bed half a year, looks into the patient's waist twinge, to the lower limb radiation, constipation, nyctalgia is difficult sleeps, thick and greasy fur, stringy pulse gives this medicine at once, advise the bag of taking after mixing it with water every night (5 gram), wind sheltering.The 15 days state of an illness of taking medicine greatly take a turn for the better, and can descend ground movable, and pain stops substantially, and can sleep peacefully night, took medicine again 10 days, symptom more takes a turn for the better, and can make housework with descending, cooperates the Traditional Chinese Medicine for external application plaster again, only the drug of topical application once, all diseases disappear entirely, can normally go to work, follow up a case by regular visits to and do not recur half a year.
Zhang Jinmin, the man, 35 years old, live Taiyuan City's second steam power plant's dormitory, first visit on July 2 in 1994, patient 4-7 hyperosteogeny 3 years, frequent dizzy ear toot, numbness of the fingers, head movement is limited, influences work.Take this medicine, once a day, each 5 grams, symptom greatly takes a turn for the better after 16 days, take medicine again and consolidated in 10 days, and deposited plaster is once, obtains recovery from illness.
Therefore it is evident in efficacy definite to treat the bony spur hypertrophy with the present invention, and it is short to imitate journey, and toxic and side effects is little, and clinical effective rate can reach 85%.
The embodiment explanation
Embodiment 1
This example is made by the following weight Chinese medicinal raw materials:
Radix Astragali 30g Radix Paeoniae Alba 15g Radix Angelicae Sinensis 15g Olibanum 20g
Myrrha 20g Herba Ephedrae 20g Semen Strychni 30g Flos Carthami 15g
Sanguis Draxonis 10g Radix Clematidis 20g Herba speranskiae tuberculatae 10g
Manufacture method:
Earlier sand is put into iron pan, be heated to about 200 ℃, constantly stir sand simultaneously, again with the Semen Strychni input, continue to stir, be sepia or dark brown to the Semen Strychni appearance, when vesicle is heaved in inside, take out, sieve shakeout cools, and removes floss removing again, and pulverize is standby; All the other 10 flavor Chinese medicines are chosen impurity, well sifted, pulverization is mixed thoroughly with the Semen Strychni Pulveratum that has cooked, promptly gets the oral Chinese patent medicine of powder preparation formulation.
Above powder, one bag of every 5g (every bag contains Semen Strychni Pulveratum 0.86g approximately);
Usage and dosage: the adult takes medicine once every day, each 5g, and take after mixing it with water for about 2.5 liang with yellow wine evening just before going to bed, and child and weakling's consumption cut down according to the circumstance, and the period in a medicine food that avoids pungent food is avoided wind.Medication 8 days was a course of treatment.
The visual conditions of patients of period in a medicine cooperates the Traditional Chinese Medicine for external application plaster, and sb.'s illness took a favorable turn to quicken.
Embodiment 2
This example is made (b is Unit Weight part) by the following weight Chinese medicinal raw materials:
Radix Astragali 35b Radix Paeoniae Alba 18b Radix Angelicae Sinensis 12b Olibanum 16b
Myrrha 24b Herba Ephedrae 24b Semen Strychni 25b Flos Carthami 12b
Sanguis Draxonis 12b Radix Clematidis 24b Herba speranskiae tuberculatae 8b
Embodiment 3
This example is made (b is Unit Weight part) by the following weight Chinese medicinal raw materials:
Radix Astragali 25b Radix Paeoniae Alba 12b Radix Angelicae Sinensis 18b Olibanum 24b
Myrrha 16b Herba Ephedrae 16b Semen Strychni 35b Flos Carthami 18b
Sanguis Draxonis 8b Radix Clematidis 16b Herba speranskiae tuberculatae 12b.
Claims (2)
1, the treatment hyperosteogeny Chinese patent medicine " collateral dredging disappear perverse loose ", it is characterized in that this Chinese patent medicine is to be made by the following weight Chinese medicinal raw materials:
Radix Astragali 25-35 part Radix Paeoniae Alba 12-18 part Radix Angelicae Sinensis 12-18 part Olibanum 16-24 part
Myrrha 16-24 part Herba Ephedrae 16-24 part Semen Strychni 25-35 part Flos Carthami 12-18 part
Sanguis Draxonis 8-12 part Radix Clematidis 16-24 part Herba speranskiae tuberculatae 8-12 part
Its manufacturing process is: sand is put into iron pan, be heated to about 200 ℃, constantly stir sand simultaneously, again with the Semen Strychni input, continue to stir, be sepia or dark brown to the Semen Strychni appearance, when vesicle is heaved in inside, take out, sieve shakeout cools, and removes floss removing again, and pulverize is standby; All the other 10 flavor Chinese medicines are chosen impurity, well sifted, pulverization is mixed thoroughly with the Semen Strychni Pulveratum that has cooked, promptly gets the oral Chinese patent medicine of powder preparation formulation.
2, the Chinese patent medicine of treatment hyperosteogeny according to claim 1 " collateral dredging Xiaocisan " is characterized in that this Chinese patent medicine is to be made by the following weight Chinese medicinal raw materials:
Radix Astragali 30g Radix Paeoniae Alba 15g Radix Angelicae Sinensis 15g Olibanum 20g
Myrrha 20g Herba Ephedrae 20g Semen Strychni 30g Flos Carthami 15g
Sanguis Draxonis 10g Radix Clematidis 20g Herba speranskiae tuberculatae 10g
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97105284A CN1057692C (en) | 1997-07-30 | 1997-07-30 | Chinese patent drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97105284A CN1057692C (en) | 1997-07-30 | 1997-07-30 | Chinese patent drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1179958A CN1179958A (en) | 1998-04-29 |
| CN1057692C true CN1057692C (en) | 2000-10-25 |
Family
ID=5167814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97105284A Expired - Fee Related CN1057692C (en) | 1997-07-30 | 1997-07-30 | Chinese patent drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1057692C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112076273A (en) * | 2020-10-20 | 2020-12-15 | 尼士杰 | Pain-relieving medicine for treating rheumatism and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1068962A (en) * | 1992-07-13 | 1993-02-17 | 李去病 | The preparation technology of yugusan |
-
1997
- 1997-07-30 CN CN97105284A patent/CN1057692C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1068962A (en) * | 1992-07-13 | 1993-02-17 | 李去病 | The preparation technology of yugusan |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1179958A (en) | 1998-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327420B (en) | Chinese medicinal composition for setting bones and replenishing muscles and ligaments | |
| CN1448176A (en) | Medicine for treating osteoporosis and its preparing process | |
| CN1739700A (en) | Rheumatism treating plaster and its prepn | |
| CN103565969B (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| CN1127969C (en) | Hyperosteogeny treating medicine | |
| CN1079029C (en) | Medical capsule for treating bone rheumatism and preparing process | |
| CN1057692C (en) | Chinese patent drug | |
| CN1067571C (en) | Chinese medicine capsule for treating lumbar and cervical protrusion | |
| CN1201765C (en) | Chinese medicine ointment for treating arthrosis | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN101496838A (en) | Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof | |
| CN1907410A (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN1112206C (en) | Bone fracture setting medicine powder | |
| CN1151814C (en) | Composite Chinese medicine for treating rheumatic Bi syndrome | |
| CN1059327C (en) | Inflammation diminishing and asthma stopping cream | |
| CN1259065C (en) | A kind of traditional Chinese medicine preparation for fast bone setting | |
| CN102048878A (en) | Plaster for assisting in treating rheumatic arthralgia and preparation method thereof | |
| CN1660330A (en) | Medication for treating necrosis of femoral head and preparation method | |
| CN111419924A (en) | A topical Chinese medicinal composition for treating various muscle and bone diseases, and its preparation device | |
| CN1059570C (en) | Medicine for curing enuresis | |
| CN1150921C (en) | Medicine for treating algia disease and its preparing process | |
| CN1256127C (en) | Chinese patent medicine for injury of muscle and joint and its preparation | |
| CN102836346B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN1055231C (en) | Medicine for treating hyperosteogeny disease and preparing process thereof | |
| CN101904992B (en) | Chinese medicinal preparation for treating traumatic injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |